Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
BioBlast®
Biosimilars Deals 2023
Diversity
Masterclasses
Other Podcasts
Other Updates
Our Awards
Patent Litigation
Patents
PipCast®
PTE
Webinars

Medicines for Europe releases white paper reviewing barriers to market entry

Nov 4, 2020

Medicines for Europe released a white paper which reviews the barriers to generic and biosimilar market entry. In particular, the unlimited number of divisional patents which can be filed in the EU, product hopping and anticompetitive rebates were identified as significant barriers to market entry for generics and biosimilars.

Print Page Mail Article